Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis | Zendy

Afsaneh Shirani | Zendy; Yinshan Zhao | Zendy; Mohammad Ehsanul Karim | Zendy; Charity Evans | Zendy; Elaine Kingwell | Zendy; Mia L. van der Kop | Zendy; Joël Oger | Zendy; Paul Gustafson | Zendy; John Petkau | Zendy; Helen Tremlett | Zendy

Open Access

Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis

Author(s) -

Afsaneh Shirani,

Yinshan Zhao,

Mohammad Ehsanul Karim,

Charity Evans,

Elaine Kingwell,

Mia L. van der Kop,

Joël Oger,

Paul Gustafson,

John Petkau,

Helen Tremlett

Publication year - 2012

Publication title -

jama

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.688

H-Index - 680

eISSN - 1538-3598

pISSN - 0098-7484

DOI - 10.1001/jama.2012.7625

Subject(s) - medicine , expanded disability status scale , interquartile range , cohort , multiple sclerosis , hazard ratio , propensity score matching , proportional hazards model , cohort study , interferon beta 1b , interferon beta 1a , confounding , interferon beta , confidence interval , immunology

Interferon beta is widely prescribed to treat multiple sclerosis (MS); however, its relationship with disability progression has yet to be established.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research